Overview
CVS Group plc, based in the UK, operates primarily in the veterinary services industry, providing an extensive range of services and products to the veterinary market. Established in 1999, the company has grown significantly both organically and through acquisitions, expanding its network of veterinary practices, diagnostic laboratories, pet crematoria, and e-commerce platforms. A key focus for CVS Group is the enhancement of clinical practice through the introduction of advanced veterinary technology and specialist referral services, aiming to improve standards of care across its operations. Additionally, the company is active in education and training for veterinary professionals, emphasizing continuous improvement in veterinary science and pet health management.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for CVS Group plc as of 31 December 2024 is 668.60 MM.
- The operating income for CVS Group plc as of 31 December 2024 is 45.60 MM.
- The net income for CVS Group plc as of 31 December 2024 is 2.80 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | 668.60 | 45.60 | 2.80 |
2024-09-30 | 657.95 | 48.20 | 4.50 |
2024-06-30 | 647.30 | 50.80 | 6.20 |
2023-12-31 | 613.10 | 68.50 | 35.40 |
2023-09-30 | 601.00 | 68.45 | 38.65 |
2023-06-30 | 588.90 | 68.40 | 41.90 |
2023-03-31 | 592.55 | 55.15 | 35.60 |
2022-12-31 | 576.80 | 48.00 | 29.30 |
2022-09-30 | 565.50 | 45.40 | 27.50 |
2022-06-30 | 554.20 | 42.80 | 25.70 |
2022-03-31 | 546.20 | 45.40 | 25.60 |
2021-12-31 | 538.20 | 48.00 | 25.50 |
2021-09-30 | 524.15 | 44.05 | 22.40 |
2021-06-30 | 510.10 | 40.10 | 19.30 |
2021-03-31 | 479.50 | 32.60 | 15.35 |
2020-12-31 | 448.90 | 25.10 | 11.40 |
2020-09-30 | 438.35 | 21.80 | 8.55 |
Income Statement: EPS
- The earnings per share basic for CVS Group plc as of 31 December 2024 is 0.04.
- The earnings per share diluted for CVS Group plc as of 31 December 2024 is 0.04.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | 0.04 | 0.04 |
2024-09-30 | 0.06 | 0.06 |
2024-06-30 | 0.09 | 0.09 |
2023-12-31 | 0.50 | 0.50 |
2023-09-30 | 0.54 | 0.54 |
2023-06-30 | 0.59 | 0.58 |
2023-03-31 | 0.50 | 0.50 |
2022-12-31 | 0.41 | 0.41 |
2022-09-30 | 0.39 | 0.38 |
2022-06-30 | 0.36 | 0.36 |
2022-03-31 | 0.36 | 0.36 |
2021-12-31 | 0.36 | 0.36 |
2021-09-30 | 0.32 | 0.31 |
2021-06-30 | 0.27 | 0.27 |
2021-03-31 | 0.22 | 0.22 |
2020-12-31 | 0.16 | 0.16 |
2020-09-30 | 0.12 | 0.12 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for CVS Group plc as of 31 December 2024 is 66.70 MM.
- The cash from investing activities for CVS Group plc as of 31 December 2024 is -100.40 MM.
- The cash from financing activities for CVS Group plc as of 31 December 2024 is 13.50 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | 66.70 | -100.40 | 13.50 |
2024-09-30 | 67.25 | -120.45 | 40.90 |
2024-06-30 | 67.80 | -140.50 | 68.30 |
2023-12-31 | 88.90 | -135.90 | 51.90 |
2023-09-30 | 86.70 | -117.90 | 19.90 |
2023-06-30 | 84.50 | -99.90 | -12.10 |
2023-03-31 | 82.90 | -79.30 | -14.55 |
2022-12-31 | 81.30 | -58.70 | -17.00 |
2022-09-30 | 78.40 | -51.90 | -16.05 |
2022-06-30 | 75.50 | -45.10 | -15.10 |
2022-03-31 | 61.40 | -47.15 | -16.00 |
2021-12-31 | 47.30 | -49.20 | -16.90 |
2021-09-30 | 53.75 | -42.30 | -14.75 |
2021-06-30 | 60.20 | -35.40 | -12.60 |
2021-03-31 | 75.90 | -29.00 | -23.95 |
2020-12-31 | 91.60 | -22.60 | -35.30 |
2020-09-30 | 84.60 | -21.10 | -42.15 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Management Effectiveness
- The roa for CVS Group plc as of 31 December 2024 is 0.00.
- The roe for CVS Group plc as of 31 December 2024 is 0.01.
- The roic for CVS Group plc as of 31 December 2024 is 0.01.
- The croic for CVS Group plc as of 31 December 2024 is -0.04.
- The ocroic for CVS Group plc as of 31 December 2024 is 0.12.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2024-12-31 | 0.00 | 0.01 | 0.01 | -0.04 | 0.12 |
2024-09-30 | 0.01 | 0.02 | 0.01 | -0.02 | 0.12 |
2024-06-30 | 0.06 | 0.14 | 0.06 | 0.01 | 0.16 |
2023-12-31 | 0.07 | 0.17 | 0.07 | -0.02 | 0.16 |
2023-09-30 | 0.08 | 0.19 | 0.09 | -0.06 | 0.19 |
2023-06-30 | 0.08 | 0.19 | 0.09 | -0.06 | 0.19 |
2023-03-31 | 0.07 | 0.16 | 0.08 | -0.02 | 0.18 |
2022-12-31 | 0.06 | 0.13 | 0.07 | 0.02 | 0.19 |
2022-09-30 | 0.06 | 0.13 | 0.07 | 0.02 | 0.19 |
2022-06-30 | 0.05 | 0.13 | 0.06 | 0.04 | 0.19 |
2022-03-31 | 0.05 | 0.13 | 0.06 | -0.00 | 0.15 |
2021-12-31 | 0.05 | 0.14 | 0.07 | -0.05 | 0.12 |
2021-09-30 | 0.05 | 0.12 | 0.06 | -0.01 | 0.14 |
2021-06-30 | 0.04 | 0.12 | 0.05 | 0.03 | 0.16 |
2021-03-31 | 0.03 | 0.09 | 0.04 | 0.06 | 0.20 |
2020-12-31 | 0.02 | 0.07 | 0.03 | 0.09 | 0.25 |
2020-09-30 | 0.02 | 0.05 | 0.02 | 0.06 | 0.23 |
Gross Margins
- The gross margin for CVS Group plc as of 31 December 2024 is 0.43.
- The net margin for CVS Group plc as of 31 December 2024 is 0.00.
- The operating margin for CVS Group plc as of 31 December 2024 is 0.07.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2024-12-31 | 0.43 | 0.00 | 0.07 |
2024-09-30 | 0.43 | 0.01 | 0.07 |
2024-06-30 | 0.43 | 0.06 | 0.09 |
2023-12-31 | 0.43 | 0.06 | 0.10 |
2023-09-30 | 0.43 | 0.07 | 0.10 |
2023-06-30 | 0.43 | 0.07 | 0.10 |
2023-03-31 | 0.43 | 0.06 | 0.09 |
2022-12-31 | 0.43 | 0.05 | 0.08 |
2022-09-30 | 0.43 | 0.05 | 0.08 |
2022-06-30 | 0.43 | 0.05 | 0.08 |
2022-03-31 | 0.43 | 0.05 | 0.08 |
2021-12-31 | 0.43 | 0.05 | 0.09 |
2021-09-30 | 0.43 | 0.04 | 0.08 |
2021-06-30 | 0.44 | 0.04 | 0.08 |
2021-03-31 | 0.43 | 0.03 | 0.07 |
2020-12-31 | 0.43 | 0.03 | 0.06 |
2020-09-30 | 0.41 | 0.02 | 0.05 |
Identifiers and Descriptors
Central Index Key (CIK) |